Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
AVI BioPharma, Inc. Announces Proposed Public Offering of Common Stock and Warrants
AVI BioPharma, 08/20/09
AVI BioPharma, Inc. , a developer of RNA–based drugs, announced that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09
Astellas Inducted into National Minority Transplant Hall of Fame
Astellas, 12/09/09
Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Amgen, 12/08/09
Article Search
Sponsor